Intestinal Microbiota: Immunity, Recovery and Metabolic Health
- Conditions
- Healthy
- Interventions
- Dietary Supplement: Whey protein hydrolysate milk productDietary Supplement: Placebo ComparatorDietary Supplement: Postbiotic and whey protein hydrolysate milk product
- Registration Number
- NCT06355089
- Lead Sponsor
- University of Turku
- Brief Summary
The aim of this intervention study is to investigate the effect of a specific postbiotic (Lacticaseibacillus rhamnosus GG = LGG) and whey protein on immunity, recovery, and weight management in young adults. The objective is based on previous knowledge about the health-promoting effects of these factors. A new goal is to study the combined effect of the postbiotic and whey protein. The results of the study can be utilized to promote the health of the young adults.
- Detailed Description
The study is a randomized, double-blind, 3-arm intervention involving young adults (n=160). Participants are randomized into three groups to receive different study product, and differences among the groups will be compared, for example, in terms of gut microbiota, weight changes, and inflammatory markers derived from blood samples.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 160
- healthy
- medicines and diseases that significantly affect the functioning of the stomach and intestines (e.g. irritable bowel syndrome)
- antibiotic treatment within 3 months
- asthma medication
- milk allergy (protein); the study product is lactose-free
- the participant must adhere to avoid the use of foods or nutritional supplements containing probiotics, and high-protein products, e.g. whey protein powders and high-protein snack bars
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Whey protein hydrolysate milk product Whey protein hydrolysate milk product Use of milk product with whey protein hydrolysate Placebo milk product Placebo Comparator Use of low protein milk product Postbiotic and whey protein hydrolysate milk product Postbiotic and whey protein hydrolysate milk product Use of milk product with whey protein hydrolysate and Lacticaseibacillus rhamnosus GG
- Primary Outcome Measures
Name Time Method Concentrations of inflammatory markers from the blood samples At the baseline (week 0) and after eight weeks (last visit) hs-CRP (High-Sensitivity C-Reactive Protein), haptoglobin, suPAR (soluble urokinase-type Plasminogen Activator Receptor)
- Secondary Outcome Measures
Name Time Method Waist circumference of the participant At the baseline (week 0) and after eight weeks (last visit) Waist circumference
Changes in recovery During intervention (Eight weeks) Monitoring recovery using a sports watch.
Development of physical fitness At the baseline (week 0) and after eight weeks (last visit) Based on walking test
Blood pressure At the baseline (week 0), at four weeks and after eight weeks (last visit) Blood pressure
Infections during the intervention During intervention (Eight weeks) Self-reported infections during the intervention
Changes in the sleep quality During intervention (Eight weeks) Monitoring sleep quality using a sports watch.
Changes in the gut microbiota composition, diversity and function At the baseline (week 0) and after eight weeks (last visit) Gut microbiota composition and function in feces by metagenomics shotgun sequencing
Weight of the participant At the baseline (week 0), at four weeks and after eight weeks (last visit) Weight
BMI At the baseline (week 0), at four weeks and after eight weeks (last visit) Body Mass Index (BMI)
Trial Locations
- Locations (1)
University of Turku
š«š®Turku, Finland